Inmune Bio (INMB) EBT (2018 - 2026)
Inmune Bio's (INMB) quarterly EBT came in at -$1.5 million in Q2 2026, up 93.99% year-over-year from -$760852.5 in Q2 2025, and up 74.6% quarter-over-quarter from -$5.8 million in Q1 2026.
Powered by 
Analysis
Inmune Bio (INMB) EBT (2018 - 2026) Analysis & Trends
Inmune Bio has disclosed EBT across 9 years of filings, most recently posting -$1.5 million for Q2 2026.
- In Q2 2026, EBT rose 93.99% year-over-year to -$1.5 million; the TTM figure through Jun 2026 stood at -$20.2 million (up 64.08% YoY), while the FY2025 annual figure was -$47.4 million, down 11.14% from the prior year.
- EBT came in at -$1.5 million for Q2 2026 at Inmune Bio, up from -$5.8 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$1.5 million in Q2 2026 to a low of -$24.6 million in Q2 2025.
- Average EBT over 5 years is -$8.6 million, with a median of -$7.6 million recorded in 2022.
- Year-over-year, EBT slumped 149.07% in 2025 and soared 93.99% in 2026.
- Over 5 years, EBT stood at -$5.8 million in 2022, then sank by 44.15% to -$8.4 million in 2023, then declined by 12.6% to -$9.5 million in 2024, then surged by 42.18% to -$5.5 million in 2025, then jumped by 73.04% to -$1.5 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$1.5 million in Q2 2026, -$5.8 million in Q1 2026, and -$5.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 66.08 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -90.19 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | -48.69 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 55.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -79.22 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -119.07 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 20.07 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -1.75 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 2.23 Mn |
| 10 | Inmune Bio | 67.48 Mn | 49.06 Mn | - | -1.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.48 Mn |
| Mar 31, 2026 | -5.81 Mn |
| Dec 31, 2025 | -5.47 Mn |
| Sep 30, 2025 | -7.43 Mn |
| Jun 30, 2025 | -24.57 Mn |
| Mar 31, 2025 | -9.91 Mn |
| Dec 31, 2024 | -9.47 Mn |
| Sep 30, 2024 | -12.29 Mn |
| Jun 30, 2024 | -9.87 Mn |
| Mar 31, 2024 | -11.02 Mn |
| Dec 31, 2023 | -8.41 Mn |
| Sep 30, 2023 | -8.56 Mn |
| Jun 30, 2023 | -6.50 Mn |
| Mar 31, 2023 | -6.54 Mn |
| Dec 31, 2022 | -5.83 Mn |
| Sep 30, 2022 | -7.73 Mn |
| Jun 30, 2022 | -6.84 Mn |
| Mar 31, 2022 | -6.90 Mn |
| Dec 31, 2021 | -9.67 Mn |
| Sep 30, 2021 | -9.46 Mn |